Grants and Contributions:
Title:
OpenMRS integration with the Signalytic platform
Agreement Number:
998893
Agreement Value:
$74,618.00
Agreement Date:
Nov 7, 2022 - Dec 31, 2023
Description:
The Signalytic platform is a dedicated hardware and software system that provides digital connectivity and data service in locations without power or internet. The platform is actively developed and deployed to address health data networking problems in Eastern Africa. OpenMRS is an open source EMR software product that has widespread adoption and support across the world. Lack of infrastructure limits its application in places where Signalytic is active. This project explores the integration of OpenMRS with the existing Signalytic Platform.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V5T 0C8
Reference Number:
172-2022-2023-Q3-998893
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
776518086
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 153 days.
Amendment Date
Jun 28, 2023
Recipient's Operating Name:
Signalytic
Recipient's Legal Name:
Wendepunkt Medical Innovations Inc
Federal Riding Name:
Vancouver East
Federal Riding Number:
59035
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512
Amendments: